Immunome, Inc.IMNMNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-190.92M
↓ 296% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
$-48.17M
Historical baseline
PeriodValueYoY Change
2025$-190.92M-72.3%
2024$-110.79M-1364.0%
2023$-7.57M+73.6%
2022$-28.69M-57.4%
2021$-18.23M-50.2%
2020$-12.13M-26.4%
2019$-9.60M-29.6%
2018$-7.41M-